Publisher
Springer International Publishing
Reference44 articles.
1. Bashir H, Jankovic J (2018) Deutetrabenazine for the treatment of Huntington’s chorea. Expert Rev Neurother 18(8):625–631
2. Blake MI, Crespi HL, Katz JJ (1975) Studies with deuterated drugs. J Pharm Sci 64(3):367–391
3. Cargnin S, Serafini M, Pirali T (2019) A primer of deuterium in drug design. Future Med Chem 11(16):2039–2042
4. DeWitt SH, Maryanoff BE (2018) Deuterated drug molecules: focus on FDA-approved deutetrabenazine. Biochemist 57(5):472–473
5. Dunsaed C, Dornish J, Aastveit T, Pettersen E (1993) Invivo pharmacokinetics of the antitumor agent 4,6-benzylidene-d-glucose (bg) and a deuterated analog 4,6-benzylidene-d1-d-glucose (p-1013) in mice, rats and dogs. Int J Oncol 2(1):61–66